EW

Q: What is the price of Edwards Lifesciences (EW) today?

The current price of Edwards Lifesciences (EW) is $ 80.10, representing a 14.59% gain over the past year. The stock began the year trading around $ 85.25 and is currently priced at $ 80.10. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Edwards Lifesciences (EW) pay dividends?

Edwards Lifesciences (EW) did not pay dividends over the past year.

Edwards Lifesciences Corp.

Price

$ 80.10

return (12m)

14.59%

p/e

43.93

p/bv

0.00

DIVIDEND YIELD

0.00%

EW price

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment EW

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-6.63%

3 months

-5.91%

1 year

14.59%

2 years

-12.47%

5 years

-6.67%

10 years

127.24%

Fundamentals EW

review the fundamentals of Edwards Lifesciences shares

P/E

43.93

Sector: -2.15 Industry: 0.38

P/S (PSR)

7.75

Sector: 1.92 Industry: 2.43

P/BV

0.00

Sector: 2.10 Industry: 2.24

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

0.00%

Sector: -25.33% Industry: -23.48%

ROE

0.00%

Sector: -29.65% Industry: -31.19%

ROIC

12.34%

Sector: -418.66% Industry: -76.94%

NET MARGIN

17.64%

Sector: -27.82% Industry: -30.15%

GROSS MARGIN

78.01%

Sector: 44.91% Industry: 51.03%

OPERATING MARGIN

26.97%

Sector: -22.85% Industry: -26.89%

EV/EBITDA

27.48

Sector: -0.40 Industry: 1.11

EV/EBIT

28.73

Sector: -1.68 Industry: -0.22

PRICE-TO-ASSETS

Sector: 1.13 Industry: 1.20

BVPS

Sector: 3.83 Industry: 5.09

EPS

1.85

Sector: -0.89 Industry: -0.80

EQUITY-TO-ASSETS RATIO

Sector: 0.44 Industry: 0.46

LIABILITIES / ASSETS

Sector: 0.46 Industry: 0.50

CAGR REVENUE 5 YEARS

3.01%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-6.57%

Sector: - Industry: -

Fundamentals EW

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.57	35.11	86.53%	0.67%	$ 837.34 B	31.66%
ISRG	56.19	8.94	15.92%	0.00%	$ 160.48 B	28.38%
TMO	27.56	3.45	12.52%	0.35%	$ 184.79 B	15.05%
SNY	12.82	1.39	10.86%	4.62%	$ 116.90 B	18.68%
NVS	21.09	6.34	30.04%	4.53%	$ 294.97 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.09	2.26	9.38%	3.27%	$ 111.15 B	13.00%
CVS	52.79	1.24	2.35%	3.62%	$ 93.33 B	0.44%
GSK	14.82	5.29	35.71%	2.96%	$ 113.04 B	17.48%
BSX	32.15	0.00	0.00%	0.00%	$ 93.16 B	14.44%
TMDX	17.99	7.24	40.22%	0.00%	$ 3.42 B	31.43%
HCA	15.86	-38.82	-244.82%	0.62%	$ 107.58 B	8.97%
IDXX	43.01	28.38	65.99%	0.00%	$ 45.56 B	24.62%
RMD	22.02	5.18	23.51%	1.04%	$ 32.72 B	27.53%
DHR	37.39	2.57	6.88%	0.67%	$ 135.12 B	14.71%
INMD	9.26	1.27	13.73%	0.00%	$ 868.77 M	25.32%
PHG	24.85	2.00	8.06%	3.27%	$ 25.78 B	5.07%
FMS	11.36	0.77	6.75%	3.51%	$ 12.82 B	5.02%
SYK	39.12	5.66	14.48%	1.03%	$ 126.98 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

EW Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Edwards Lifesciences

Edwards Lifesciences Corp.

Average Investor10 user rating

4.0 (12 people)

United States

27 years

Founded: 1999

2000

Time since IPO - 26 years

14.900

Employees

Edwards Lifesciences Corp. (United States) is listed on the NYSE and has a market capitalization of $47.01 Billions, with shareholders equity totaling $-.

The company employs approximately 14.900 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Edwards Lifesciences Corp. reported $6.07 Billions in revenue, generating net income of $1.07 Billion.

Key financial metrics include a P/E ratio of 43.93, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker EW.

Market cap

$ 47.01 Billions

Net worth

$ -

Assets

$ -

Total Shares Outstanding

580.00 Millions

580,000,000

Average Daily Trading Volume

$ 4.76 Millions

$ 4,761,231.34

Sector

Health

Industry

Medical Supplies and Equipment

revenue by Business Segment Edwards Lifesciences

Revenue by Region Edwards Lifesciences

EW revenue and profits

Financial Results EW

DRAG THE FRAME TO SEE MORE DATA

EW cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 79.16 20,24% (12M)

P/E

52.79

3.62%

ROE

2.35%

P/BV

1.24

CI - Cigna

$ 278.37 --13,14% (12M)

P/E

10.45

2.26%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 37.27 --40,26% (12M)

P/E

-2.59

0.00%

ROE

-33.28%

P/BV

0.86

HUM - Humana

$ 197.45 --30,67% (12M)

P/E

17.96

1.99%

ROE

6.70%

P/BV

1.20

HCA - HCA Healthcare

$ 510.27 53,37% (12M)

P/E

15.86

0.62%

ROE

-244.82%

P/BV

-38.82

LLY - Eli Lilly

$ 959.08 31,90% (12M)

P/E

40.57

0.67%

ROE

86.53%

P/BV

35.11

NVS - Novartis

$ 155.47 58,82% (12M)

P/E

21.09

4.53%

ROE

30.04%

P/BV

6.34